Impact of improving negative symptoms on functioning in patients with schizophrenia: a post-hoc analysis of a proof-of-concept study

被引：0
作者：
Blaettler, T. [1 ]
Edgar, C. [2 ]
Garibaldi, G. [3 ]
机构：
[1] F Hoffmann La Roche Ltd, PDND Clin Dev CNS, Basel, Switzerland
[2] Roche Prod Ltd, Welwyn Garden City, England
[3] F Hoffmann La Roche Ltd, CNS Clin Dev, Basel, Switzerland
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2012年 / 22卷
关键词：
D O I：
10.1016/S0924-977X(12)70474-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S310 / S310
页数：1
相关论文
共 50 条
  • [21] Efficacy of lurasidone in the treatment of schizophrenia with prominent negative symptoms: a post-hoc analysis of five short-term trials
    Schooler, N. R.
    Pikalov, A.
    Hsu, J.
    Cucchiaro, J.
    Goldman, R.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S558 - S558
  • [22] Efficacy of cariprazine on negative symptoms in patients with acute schizophrenia: A post hoc analysis of pooled data
    Earley, Willie
    Guo, Hua
    Daniel, David
    Nasrallah, Henry
    Durgam, Suresh
    Zhong, Yan
    Patel, Mehul
    Barabassy, Agota
    Szatmari, Balazs
    Nemeth, Gyorgy
    SCHIZOPHRENIA RESEARCH, 2019, 204 : 282 - 288
  • [23] Efficacy of Karxt on Negative Symptoms in Acute Schizophrenia: A Post Hoc Analysis of Participants With Prominent Negative Symptoms
    Horan, William
    Claxton, Amy
    Targum, Steven D.
    Yohn, Samantha E.
    Kaul, Inder
    Sawchak, Sharon
    Miller, Andrew C.
    Paul, Steven M.
    Brannan, Stephen K.
    BIOLOGICAL PSYCHIATRY, 2024, 95 (10) : S268 - S269
  • [24] Impact of negative symptoms on functioning of patients with schizophrenia in five European countries
    Leeuwenkamp, O.
    Perry, R.
    Morlock, R.
    Jones, E.
    Taylor, T.
    VALUE IN HEALTH, 2006, 9 (06) : A323 - A323
  • [25] Residual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysis
    Romera, Irene
    Perez, Victor
    Ciudad, Antonio
    Caballero, Luis
    Roca, Miguel
    Polavieja, Pepa
    Gilaberte, Inmaculada
    BMC PSYCHIATRY, 2013, 13
  • [26] Residual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysis
    Irene Romera
    Víctor Pérez
    Antonio Ciudad
    Luis Caballero
    Miguel Roca
    Pepa Polavieja
    Inmaculada Gilaberte
    BMC Psychiatry, 13
  • [27] The impact of lurasidone on functioning and indirect costs in adults with bipolar depression: a post-hoc analysis
    Niu, Xiaoli
    Dembek, Carole
    Fan, Qi
    Mao, Yongcai
    Divino, Victoria
    Burch, Steven
    Tocco, Michael
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 152 - 159
  • [28] Motivational and Behavioral Activation as an Adjunct to Psychiatric Rehabilitation for Mild to Moderate Negative Symptoms in Individuals with Schizophrenia: A Proof-of-Concept Pilot Study
    Choi, Kee-Hong
    Jaekal, Eunju
    Lee, Ga-Young
    FRONTIERS IN PSYCHOLOGY, 2016, 7
  • [29] An initial animal proof-of-concept study for central administration of clozapine to schizophrenia patients
    Abrams, Daniel J.
    Zheng, Lijun
    Choo, Kevin S.
    Yang, Jun J.
    Wei, Wei
    Anchordoquy, Thomas J.
    Zawia, Nasser H.
    Stevens, Karen E.
    SCHIZOPHRENIA RESEARCH, 2008, 100 (1-3) : 86 - 96
  • [30] Impact of age in critically Ill infected patients: a post-hoc analysis of the INFAUCI study
    Sónia Bastos Moreira
    João Pedro Baptista
    João Gonçalves-Pereira
    José Manuel Pereira
    Orquídea Ribeiro
    Claúdia Camila Dias
    Filipe Froes
    José-Artur Paiva
    European Geriatric Medicine, 2021, 12 : 1057 - 1064
12345